Atrial-specific LKB1 knockdown represents a novel mouse model of atrial cardiomyopathy with spontaneous atrial fibrillation

Atrial-specific LKB1 knockdown represents a novel mouse model of atrial cardiomyopathy with spontaneous atrial fibrillation

Opis bibliograficzny
Główni autorzy:	Hulsurkar, MM, Lahiri, SK, Moore, O, Moreira, LM, Abu-Taha, I, Kamler, M, Dobrev, D, Nattel, S, Reilly, SN, Wehrens, XHT
Format:	Journal article
Język:	English
Wydane:	Lippincott, Williams and Wilkins 2021

Podobne zapisy

Mechanisms of atrial fibrillation
od: Wijesurendra, RS, i wsp.
Wydane: (2019)

Molecular Basis of Atrial Nitroso-Redox Imbalance in Permanent Human Atrial Fibrillation
od: Reilly, S, i wsp.
Wydane: (2009)

Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.
od: van Walraven, C, i wsp.
Wydane: (2009)

Atrial fibrillation and bisphosphonate therapy.
od: Pazianas, M, i wsp.
Wydane: (2010)

Stroke prevention in atrial fibrillation
od: Hobbs, F
Wydane: (2003)

The clinical epidemiology of atrial fibrillation in a population cohort and methods to identify those at risk of atrial fibrillation
od: Gardezi, S
Wydane: (2019)

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
od: Camm, A, i wsp.
Wydane: (2010)

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
od: Camm, A, i wsp.
Wydane: (2010)

One hundred years of atrial fibrillation.
od: Aronson, J
Wydane: (2005)

A mathematical model for atrial fibrillation
od: Berger, Ronald David
Wydane: (2006)

Atrial fibrillation and the use of oral bisphosphonates.
od: Pazianas, M, i wsp.
Wydane: (2011)

Atrial fibrillation is associated with cardiac hypoxia.
od: Gramley, F, i wsp.
Wydane: (2010)

Anticoagulant management in patients with atrial fibrillation.
od: Fitzmaurice, D, i wsp.
Wydane: (2009)

Should we screen for atrial fibrillation?
od: Lown, M, i wsp.
Wydane: (2017)

Treatment pathways for patients with atrial fibrillation.
od: Hodgkinson, J, i wsp.
Wydane: (2012)

Strategies in the surgical management of atrial fibrillation
od: Harling, L, i wsp.
Wydane: (2011)

Predictors of clinically significant atrial fibrillation in the NHLBI hypertrophic cardiomyopathy registry (HCMR)
od: Kramer, C, i wsp.
Wydane: (2020)

Leveraging 3D Atrial Geometry for the Evaluation of Atrial Fibrillation: A Comprehensive Review
od: Sharp, AJ, i wsp.
Wydane: (2024)

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference.
od: Kirchhof, P, i wsp.
Wydane: (2013)

Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study
od: Raman, B, i wsp.
Wydane: (2021)

ATRIAL SOURCES OF REACTIVE OXYGEN SPECIES VARY WITH THE SUBSTRATE AND DURATION OF ATRIAL FIBRILLATION: IMPLICATIONS FOR THE ANTIARRHYTHMIC EFFECT OF STATINS
od: Reilly, S, i wsp.
Wydane: (2011)

Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins
od: Reilly, S, i wsp.
Wydane: (2011)

Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins.
od: Reilly, S, i wsp.
Wydane: (2011)

Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins.
od: Reilly, SN, i wsp.
Wydane: (2011)

Digitalis: a dangerous drug in atrial fibrillation?
od: Testa, L, i wsp.
Wydane: (2008)

Atrial fibrillation: a developmental point of view.
od: Mommersteeg, M, i wsp.
Wydane: (2009)

Molecular mechanisms underlying the development of Atrial Fibrillation
od: Stefanini, M
Wydane: (2018)

Measurement of blood pressure in people with atrial fibrillation
od: Clark, CE, i wsp.
Wydane: (2019)

Choosing antithrombotics for atrial fibrillation in primary care
od: Mustafa, M, i wsp.
Wydane: (2020)

Cerebrovascular disease in dementia: the importance of atrial fibrillation.
od: Ratcliffe, P, i wsp.
Wydane: (1985)

Screening for atrial fibrillation: A call for evidence
od: Jones, N, i wsp.
Wydane: (2019)

Paracrine signalling by cardiac calcitonin controls atrial fibrogenesis and arrhythmia
od: Moreira, LM, i wsp.
Wydane: (2020)

Improving the diagnosis of heart failure in patients with atrial fibrillation
od: Bunting, KV, i wsp.
Wydane: (2021)

Inter−subject variability in human atrial action potential in sinus rhythm versus atrial fibrillation patients
od: Sánchez, C, i wsp.
Wydane: (2014)

THE PREVALENCE OF LEFT ATRIAL APPENDAGE THROMBUS IN PATIENTS UNDERGOING CATHETER ABLATION FOR ATRIAL FIBRILLATION MAINTAINED ON WARFARIN
od: Herring, N, i wsp.
Wydane: (2012)

Modulation of atrial electrophysiology and oxidative stress by the endogenous peptide hormone apelin: implications in human atrial fibrillation
od: Kim, Y, i wsp.
Wydane: (2011)

Novel computational analysis of left atrial anatomy improves prediction of atrial fibrillation recurrence after ablation
od: Varela, M, i wsp.
Wydane: (2017)

MYOCARDIAL O2-AND ONOO-GENERATION IN CHRONIC ATRIAL FIBRILLATION
od: Margaritis, M, i wsp.
Wydane: (2011)

Different sources of oxidant stress in the early and late stage of atrial fibrillation
od: Reilly, SN, i wsp.
Wydane: (2008)

Atrial fibrillation is associated with left ventricular dysfunction and impaired myocardial energetics that persist despite catheter ablation: Is atrial fibrillation the chicken or the egg?
od: Wijesurendra, R, i wsp.
Wydane: (2016)